Schedule of Warrant Activity (Details) |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
shares
| |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Issued | 3,694,894 |
| Outstanding at June 30, 2026 | 15,500 |
| Acquisition Related Warrants [Member] | |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Outstanding at December 31, 2025 | 15,500 |
| Issued | |
| Expired | |
| Forfeited/Cancelled | |
| Exercised | |
| Outstanding at June 30, 2026 | 15,500 |
| Pre Funded Warrants [Member] | |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Outstanding at December 31, 2025 | |
| Issued | 1,592,532 |
| Expired | |
| Forfeited/Cancelled | |
| Exercised | (1,192,532) |
| Outstanding at June 30, 2026 | 400,000 |
| Warrant [Member] | |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Outstanding at December 31, 2025 | |
| Issued | 3,294,894 |
| Expired | |
| Forfeited/Cancelled | |
| Exercised | |
| Outstanding at June 30, 2026 | 3,294,894 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|